Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $286.55 million. The enterprise value is $264.42 million.
| Market Cap | 286.55M |
| Enterprise Value | 264.42M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 42.42 million shares outstanding. The number of shares has increased by 32.72% in one year.
| Shares Outstanding | 42.42M |
| Shares Change (YoY) | +32.72% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 39.70% |
| Owned by Institutions (%) | 42.55% |
| Float | 15.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.30 |
| Forward PS | 11.82 |
| PB Ratio | 14.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 51.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 2.30.
| Current Ratio | 4.55 |
| Quick Ratio | 4.34 |
| Debt / Equity | 2.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.91 |
Financial Efficiency
Return on equity (ROE) is -147.00% and return on invested capital (ROIC) is -100.74%.
| Return on Equity (ROE) | -147.00% |
| Return on Assets (ROA) | -86.60% |
| Return on Capital (ROIC) | -100.74% |
| Revenue Per Employee | $51,240 |
| Profits Per Employee | -$669,950 |
| Employee Count | 100 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.97% in the last 52 weeks. The beta is 1.91, so VRCA's price volatility has been higher than the market average.
| Beta (1Y) | 1.91 |
| 52-Week Price Change | +10.97% |
| 50-Day Moving Average | 5.80 |
| 200-Day Moving Average | 5.03 |
| Relative Strength Index (RSI) | 62.72 |
| Average Volume (30 Days) | 135,001 |
Short Selling Information
The latest short interest is 4.18 million, so 9.87% of the outstanding shares have been sold short.
| Short Interest | 4.18M |
| Short Previous Month | 4.40M |
| Short % of Shares Out | 9.87% |
| Short % of Float | 27.76% |
| Short Ratio (days to cover) | 22.54 |
Income Statement
In the last 12 months, VRCA had revenue of $5.12 million and -$67.00 million in losses. Loss per share was -$1.48.
| Revenue | 5.12M |
| Gross Profit | 4.38M |
| Operating Income | -65.76M |
| Pretax Income | -67.00M |
| Net Income | -67.00M |
| EBITDA | -62.20M |
| EBIT | -63.03M |
| Loss Per Share | -$1.48 |
Balance Sheet
The company has $69.55 million in cash and $45.51 million in debt, giving a net cash position of $24.04 million or $0.57 per share.
| Cash & Cash Equivalents | 69.55M |
| Total Debt | 45.51M |
| Net Cash | 24.04M |
| Net Cash Per Share | $0.57 |
| Equity / Book Value | 19.76M |
| Book Value Per Share | 0.47 |
| Working Capital | 60.51M |
Cash Flow
In the last 12 months, operating cash flow was -$38.58 million and capital expenditures -$362,000, giving a free cash flow of -$38.94 million.
| Operating Cash Flow | -38.58M |
| Capital Expenditures | -362,000 |
| Free Cash Flow | -38.94M |
| FCF Per Share | -$0.86 |
Margins
Gross margin is 85.44%, with operating and profit margins of -1,283.35% and -1,307.47%.
| Gross Margin | 85.44% |
| Operating Margin | -1,283.35% |
| Pretax Margin | -1,307.47% |
| Profit Margin | -1,307.47% |
| EBITDA Margin | -1,213.84% |
| EBIT Margin | -1,230.15% |
| FCF Margin | -759.93% |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.72% |
| Shareholder Yield | -32.72% |
| Earnings Yield | -23.23% |
| FCF Yield | -13.50% |
Analyst Forecast
The average price target for VRCA is $11.25, which is 65.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.25 |
| Price Target Difference | 65.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 128.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VRCA has an Altman Z-Score of -2.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.75 |
| Piotroski F-Score | 1 |